Skip to Content

Verapamil Pregnancy and Breastfeeding Warnings

Verapamil is also known as: Calan, Calan SR, Covera-HS, Isoptin, Isoptin IV, Isoptin SR, Verelan, Verelan PM

Verapamil Pregnancy Warnings

Use is recommended only if clearly needed and the benefit outweighs the risk. AU TGA pregnancy category: C US FDA pregnancy category: C Comments: -The IV formulation should be avoided for the first 2 trimesters of pregnancy. -Newborns exposed to this drug should be monitored for fetal hypoxia.

Animal studies have failed to reveal evidence of teratogenicity; however, there was evidence of embryolethality and retarded fetal growth/fetotoxicity at doses which produced maternal toxicity. This drug crosses the human placenta and can be detected in umbilical vein blood during delivery. There are no controlled data in human pregnancy. AU TGA pregnancy category C: Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing, harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible. Accompanying texts should be consulted for further details. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Verapamil Breastfeeding Warnings

In case studies where verapamil concentration in human milk was calculated, the nursing infant doses ranged from less than 0.01% to 0.1% of the mother's dose. Possible infant exposure should be considered when verapamil is administered to a nursing woman.

Use is not recommended and a decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Yes

See references

References for pregnancy information

  1. "Product Information. Verelan PM (verapamil)." Schwarz Pharma, Mequon, WI.
  2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  3. Cerner Multum, Inc. "Australian Product Information." O 0
  4. "Product Information. Covera-HS (verapamil)." Searle, Skokie, IL.
  5. "Product Information. Calan (verapamil)." Searle, Skokie, IL.
  6. "Product Information. Isoptin (verapamil)." Knoll Pharmaceutical Company, Whippany, NJ.

References for breastfeeding information

  1. "Product Information. Calan (verapamil)." Searle, Skokie, IL.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):
  3. "Product Information. Isoptin (verapamil)." Knoll Pharmaceutical Company, Whippany, NJ.
  4. Cerner Multum, Inc. "Australian Product Information." O 0
  5. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  6. "Product Information. Verelan PM (verapamil)." Schwarz Pharma, Mequon, WI.
  7. "Product Information. Covera-HS (verapamil)." Searle, Skokie, IL.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide